Cardiovascular Safety of Evolocumab: a Systematic Review and Meta-Analysis

被引:0
|
作者
Chayakrit Krittanawong
Takeshi Kitai
HongJu Zhang
Tao Sun
机构
[1] Icahn School of Medicine at Mount Sinai St’ Luke and Mount Sinai West,Department of Internal Medicine
[2] Cleveland Clinic,Department of Cardiovascular Medicine, Heart and Vascular Institute
[3] Mayo Clinic,Division of Cardiovascular Disease, Department of Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:645 / 646
页数:1
相关论文
共 50 条
  • [1] Cardiovascular Safety of Evolocumab: a Systematic Review and Meta-Analysis
    Krittanawong, Chayakrit
    Kitai, Takeshi
    Zhang, HongJu
    Sun, Tao
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2016, 30 (06) : 645 - 646
  • [2] Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides
    Gorelik, Einat
    Masarwa, Reem
    Perlman, Amichai
    Rotshild, Victoria
    Muszkat, Mordechai
    Matok, Ilan
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (06)
  • [3] Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
    Guedeney, Paul
    Giustino, Gennaro
    Sorrentino, Sabato
    Claessen, Bimmer E.
    Camaj, Anton
    Kalkman, Deborah N.
    Vogel, Birgit
    Sartori, Samantha
    De Rosa, Salvatore
    Baber, Usman
    Indolfi, Ciro
    Montalescot, Gilles
    Dangas, George D.
    Rosenson, Robert S.
    Pocock, Stuart J.
    Mehran, Roxana
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 (07) : E17 - E25
  • [4] Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis
    Guedeney, Paul
    Sorrentino, Sabato
    Giustino, Gennaro
    Chapelle, Celine
    Laporte, Silvy
    Claessen, Bimmer E.
    Ollier, Edouard
    Camaj, Anton
    Kalkman, Deborah N.
    Vogel, Birgit
    De Rosa, Salvatore
    Indolfi, Ciro
    Lattuca, Benoit
    Zeitouni, Michel
    Kerneis, Mathieu
    Silvain, Johanne
    Collet, Jean-Philippe
    Mehran, Roxana
    Montalescot, Gilles
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (03) : 225 - 235
  • [5] Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis
    Castagne, Benjamin
    Viprey, Marie
    Martin, Julie
    Schott, Anne-Marie
    Cucherat, Michel
    Soubrier, Martin
    [J]. PLOS ONE, 2019, 14 (08):
  • [6] RETRACTION: A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia
    Ge, X.
    Zhu, T.
    Zeng, H.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2024, 2024
  • [7] Safety of Aspirin for Cardiovascular Disease in China: A Systematic Review and Meta-analysis
    Zhuo, Lin
    Cheng, Yinchu
    Zhang, Yang
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 321 - 321
  • [8] Efficacy and cardiovascular safety of LAMA in patients with COPD: a systematic review and meta-analysis
    Zhang, Chuchu
    Zhang, Meng
    Wang, Yalei
    Xiong, Huaiyu
    Huang, Qiangru
    Shuai, Tiankui
    Liu, Jian
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (08) : 1391 - 1398
  • [9] RETRACTED: A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia (Retracted Article)
    Ge, Xiaoyue
    Zhu, Tiantian
    Zeng, Hao
    Yu, Xin
    Li, Juan
    Xie, Shanshan
    Wan, Jinjin
    Yang, Huiyao
    Huang, Keke
    Zhang, Weifang
    [J]. BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [10] Systematic review and meta-analysis on the safety of dalbavancin
    Monteagudo-Martinez, N.
    Solis-Garcia Del Pozo, J.
    Ikuta, I.
    Galindo, Mf
    Jordan, J.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2021, 20 (09) : 1095 - 1107